Roche and Alnylam report positive topline results from Phase 2 study KARDIA-1 of zilebesiran
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Sarah currently serves as the Chief Financial Officer and Principal Accounting Officer for Criteo S.A.
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
Dr Jitendra Singh launches API Chapter of AFMC, Pune; inaugurates the first annual conference of API-AFMS Continuing Medical Education (CME) on “Emerging trends in the practice of Medicine”
Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
Subscribe To Our Newsletter & Stay Updated